Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iradimed (IRMD) Current Leases (2019 - 2025)

Iradimed (IRMD) has disclosed Current Leases for 7 consecutive years, with $59221.0 as the latest value for Q1 2025.

  • On a quarterly basis, Current Leases fell 85.86% to $59221.0 in Q1 2025 year-over-year; TTM through Mar 2025 was $59221.0, a 85.86% decrease, with the full-year FY2024 number at $153264.0, down 64.19% from a year prior.
  • Current Leases was $59221.0 for Q1 2025 at Iradimed, down from $153264.0 in the prior quarter.
  • In the past five years, Current Leases ranged from a high of $427963.0 in Q4 2023 to a low of $59221.0 in Q1 2025.
  • A 5-year average of $303403.1 and a median of $284891.0 in 2022 define the central range for Current Leases.
  • Peak YoY movement for Current Leases: surged 45.83% in 2023, then crashed 85.86% in 2025.
  • Iradimed's Current Leases stood at $276568.0 in 2021, then increased by 6.11% to $293466.0 in 2022, then soared by 45.83% to $427963.0 in 2023, then plummeted by 64.19% to $153264.0 in 2024, then crashed by 61.36% to $59221.0 in 2025.
  • Per Business Quant, the three most recent readings for IRMD's Current Leases are $59221.0 (Q1 2025), $153264.0 (Q4 2024), and $261244.0 (Q3 2024).